Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pickar

Showing results (241-250 of 268) with videos related to

Pageof 27
Sort By:
Psychopharmacology Bulletin|January 1, 1995
Pharmacologic profile of natural products used to treat psychotic illnessesI W Chung, Y S Kim, J S Ahn, et al.
Substance and Alcohol Actions/Misuse|January 1, 1980
Assay of endogenous opiate receptor ligands in human CSF and plasmaD Naber, D Pickar, R A Dionne, et al.
Neuropsychobiology|January 1, 1986
Topographic differences between normals and schizophrenics: the N120 evoked potential componentM S Buchsbaum, S V Awsare, H H Holcomb, et al.
JAMA|January 19, 1994
No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresisP V Gejman, A Ram, J Gelernter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2000
The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophreniaA Bertolino, A Breier, J H Callicott, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophreniaT J Raedler, M B Knable, D W Jones, et al.
Schizophrenia Bulletin|January 1, 1988
Neurochemistry and neuropharmacologyA J Friedhoff, D Pickar, J Axelrod, et al.
Biological Psychiatry|May 15, 1994
Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patientsM H Rapaport, C G McAllister, Y S Kim, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1993
The effect of clozapine on cognition and psychiatric symptoms in patients with schizophreniaT E Goldberg, R D Greenberg, S J Griffin, et al.
The American Journal of Psychiatry|November 1, 1981
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteersD Naber, D Pickar, R M Post, et al.
Pageof 27

Showing results (241-250 of 268) with videos related to

Sort By:
Pageof 27
Psychopharmacology Bulletin|January 1, 1995
Pharmacologic profile of natural products used to treat psychotic illnessesI W Chung, Y S Kim, J S Ahn, et al.
Substance and Alcohol Actions/Misuse|January 1, 1980
Assay of endogenous opiate receptor ligands in human CSF and plasmaD Naber, D Pickar, R A Dionne, et al.
Neuropsychobiology|January 1, 1986
Topographic differences between normals and schizophrenics: the N120 evoked potential componentM S Buchsbaum, S V Awsare, H H Holcomb, et al.
JAMA|January 19, 1994
No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresisP V Gejman, A Ram, J Gelernter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 29, 2000
The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophreniaA Bertolino, A Breier, J H Callicott, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2000
In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophreniaT J Raedler, M B Knable, D W Jones, et al.
Schizophrenia Bulletin|January 1, 1988
Neurochemistry and neuropharmacologyA J Friedhoff, D Pickar, J Axelrod, et al.
Biological Psychiatry|May 15, 1994
Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patientsM H Rapaport, C G McAllister, Y S Kim, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1993
The effect of clozapine on cognition and psychiatric symptoms in patients with schizophreniaT E Goldberg, R D Greenberg, S J Griffin, et al.
The American Journal of Psychiatry|November 1, 1981
Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteersD Naber, D Pickar, R M Post, et al.
Pageof 27